Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord blood serum eye drops for dry eye disease
IRCT20250702066328N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Stem Cell Therapies → Cell Therapies, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in dry eye syndrome (DED) comparing Artificial tears with Umbilical cord blood serum plus artificial tears (2 arms). Primary endpoints: Visual acuity, Dry eye questionnaire score and 5 more. Started Dec 2025; status: completed.
02
Drugs
human umbilical cord blood serumartificial tears
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on IRCT20250702066328N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250702066328N1.